{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:51Z","timestamp":1793329491759,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/nrcardio.2013.165","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T08:20:56Z","timestamp":1383639656000},"page":"13-23","source":"Crossref","is-referenced-by-count":233,"title":["Drug-coated balloon therapy in coronary and peripheral artery disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Robert A.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,5]]},"reference":[{"key":"BFnrcardio2013165_CR1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/01.CIR.88.3.1310","volume":"88","author":"RE Kuntz","year":"1993","unstructured":"Kuntz, R. E. & Baim, D. S. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 88, 1310\u20131323 (1993).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR2","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","volume":"111","author":"MA Costa","year":"2005","unstructured":"Costa, M. A. & Simon, D. I. Molecular basis of restenosis and drug-eluting stents. Circulation 111, 2257\u20132273 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/11316500-000000000-00000","volume":"32","author":"RA Byrne","year":"2009","unstructured":"Byrne, R. A., Sarafoff, N., Kastrati, A. & Schomig, A. Drug-eluting stents in percutaneous coronary intervention: a benefit\u2013risk assessment. Drug Saf. 32, 749\u2013770 (2009).","journal-title":"Drug Saf."},{"key":"BFnrcardio2013165_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","volume":"368","author":"GG Stefanini","year":"2013","unstructured":"Stefanini, G. G. & Holmes, D. R. Jr. Drug-eluting coronary-artery stents. N. Engl. J. Med. 368, 254\u2013265 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner, M.  et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48, 193\u2013202 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR6","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","volume":"27","author":"AV Finn","year":"2007","unstructured":"Finn, A. V.  et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 27, 1500\u20131510 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2013165_CR7","first-page":"567","volume":"57","author":"RA Byrne","year":"2009","unstructured":"Byrne, R. A., Joner, M. & Kastrati, A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 57, 567\u2013584 (2009).","journal-title":"Minerva Cardioangiol."},{"key":"BFnrcardio2013165_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacc.2005.03.069","volume":"46","author":"PW Serruys","year":"2005","unstructured":"Serruys, P. W.  et al. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). J. Am. Coll. Cardiol. 46, 253\u2013260 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR9","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/eurheartj\/ehn253","volume":"29","author":"J Mehilli","year":"2008","unstructured":"Mehilli, J.  et al. Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur. Heart J. 29, 1975\u20131982 (2008).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013165_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","volume":"96","author":"DI Axel","year":"1997","unstructured":"Axel, D. I.  et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96, 636\u2013645 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ccd.1223","volume":"53","author":"M Oberhoff","year":"2001","unstructured":"Oberhoff, M.  et al. Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery. Catheter. Cardiovasc. Interv. 53, 562\u2013568 (2001).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s003950170058","volume":"96","author":"M Oberhoff","year":"2001","unstructured":"Oberhoff, M.  et al. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res. Cardiol. 96, 275\u2013282 (2001).","journal-title":"Basic Res. Cardiol."},{"key":"BFnrcardio2013165_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0735-1097(03)01056-8","volume":"42","author":"B Scheller","year":"2003","unstructured":"Scheller, B., Speck, U., Schmitt, A., B\u00f6hm, M. & Nickenig, G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J. Am. Coll. Cardiol. 42, 1415\u20131420 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.rli.0000116125.96544.64","volume":"39","author":"U Speck","year":"2004","unstructured":"Speck, U.  et al. Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media. Invest. Radiol. 39, 182\u2013186 (2004).","journal-title":"Invest. Radiol."},{"key":"BFnrcardio2013165_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","volume":"110","author":"B Scheller","year":"2004","unstructured":"Scheller, B.  et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110, 810\u2013814 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1148\/radiol.2402051248","volume":"240","author":"U Speck","year":"2006","unstructured":"Speck, U.  et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240, 411\u2013418 (2006).","journal-title":"Radiology"},{"key":"BFnrcardio2013165_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00392-009-0008-2","volume":"98","author":"B Cremers","year":"2009","unstructured":"Cremers, B., Biedermann, M., Mahnkopf, D., B\u00f6hm, M. & Scheller, B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin. Res. Cardiol. 98, 325\u2013330 (2009).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio2013165_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1160\/TH10-11-0698","volume":"105","author":"M Joner","year":"2011","unstructured":"Joner, M.  et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb. Haemost. 105, 864\u2013872 (2011).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio2013165_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4244\/EIJV7I6A116","volume":"7","author":"PW Radke","year":"2011","unstructured":"Radke, P. W.  et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention 7, 730\u2013737 (2011).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/0885328211423784","volume":"27","author":"M Joner","year":"2013","unstructured":"Joner, M.  et al. Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis. J. Biomater. Appl. 27, 717\u2013726 (2013).","journal-title":"J. Biomater. Appl."},{"key":"BFnrcardio2013165_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.ATV.14.1.148","volume":"14","author":"JJ Rome","year":"1994","unstructured":"Rome, J. J.  et al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler. Thromb. 14, 148\u2013161 (1994).","journal-title":"Arterioscler. Thromb."},{"key":"BFnrcardio2013165_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.acvd.2012.10.004","volume":"106","author":"J Kong","year":"2013","unstructured":"Kong, J.  et al. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis. Arch. Cardiovasc. Dis. 106, 79\u201385 (2013).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"BFnrcardio2013165_CR23","doi-asserted-by":"publisher","unstructured":"Kleber, F. X.  et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin. Res. Cardiol. \n                    http:\/\/dx.doi.org\/10.1007\/s00392-013-0609-7\n                    \n                  .","DOI":"10.1007\/s00392-013-0609-7"},{"key":"BFnrcardio2013165_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4244\/EIJV7I6A114","volume":"7","author":"JL Gutierrez-Chico","year":"2011","unstructured":"Gutierrez-Chico, J. L.  et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention 7, 711\u2013722 (2011).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/heart.89.2.133","volume":"89","author":"R Virmani","year":"2003","unstructured":"Virmani, R.  et al. Drug eluting stents: are human and animal studies comparable? Heart 89, 133\u2013138 (2003).","journal-title":"Heart"},{"key":"BFnrcardio2013165_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/hc3101.092214","volume":"104","author":"CW Hwang","year":"2001","unstructured":"Hwang, C. W., Wu, D. & Edelman, E. R. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104, 600\u2013605 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/hrt.2007.118059","volume":"93","author":"B Scheller","year":"2007","unstructured":"Scheller, B., Speck, U. & B\u00f6hm, M. Prevention of restenosis: is angioplasty the answer? Heart 93, 539\u2013541 (2007).","journal-title":"Heart"},{"key":"BFnrcardio2013165_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jcin.2013.04.013","volume":"6","author":"PP Buszman","year":"2013","unstructured":"Buszman, P. P.  et al. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model. JACC Cardiovasc. Interv. 6, 883\u2013890 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR29","doi-asserted-by":"publisher","unstructured":"Yazdani, S. K.  et al. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Catheter. Cardiovasc. Interv. \n                    http:\/\/dx.doi.org\/10.1002\/ccd.24995\n                    \n                  .","DOI":"10.1002\/ccd.24995"},{"key":"BFnrcardio2013165_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4244\/EIJV9I3A62","volume":"9","author":"SJ Denardo","year":"2013","unstructured":"Denardo, S. J.  et al. Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents. EuroIntervention 9, 389\u2013397 (2013).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4244\/EIJV9I3A51","volume":"9","author":"MW Basalus","year":"2013","unstructured":"Basalus, M. W., Joner, M., von Birgelen, C. & Byrne, R. A. Polymer coatings on drug-eluting stents: Samson's hair and Achilles' heel? EuroIntervention 9, 302\u2013305 (2013).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00392-012-0415-7","volume":"101","author":"B Cremers","year":"2012","unstructured":"Cremers, B.  et al. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin. Res. Cardiol. 101, 469\u2013476 (2012).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio2013165_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/CIRCINTERVENTIONS.110.960260","volume":"4","author":"JF Granada","year":"2011","unstructured":"Granada, J. F.  et al. Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic swine. Circ. Cardiovasc. Interv. 4, 447\u2013455 (2011).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR34","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002051","volume":"127","author":"VB Kolachalama","year":"2013","unstructured":"Kolachalama, V. B.  et al. Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy. Circulation 127, 2047\u20132055 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4244\/EIJV9I1A21","volume":"9","author":"PA Lemos","year":"2013","unstructured":"Lemos, P. A.  et al. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention 9, 148\u2013156 (2013).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR36","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","volume":"355","author":"B Scheller","year":"2006","unstructured":"Scheller, B.  et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. 355, 2113\u20132124 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00392-008-0682-5","volume":"97","author":"B Scheller","year":"2008","unstructured":"Scheller, B.  et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 97, 773\u2013781 (2008).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio2013165_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","volume":"5","author":"B Scheller","year":"2012","unstructured":"Scheller, B.  et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc. Interv. 5, 323\u2013330 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.293.2.165","volume":"293","author":"A Kastrati","year":"2005","unstructured":"Kastrati, A.  et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293, 165\u2013171 (2005).","journal-title":"JAMA"},{"key":"BFnrcardio2013165_CR40","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.jacc.2005.10.078","volume":"47","author":"F Alfonso","year":"2006","unstructured":"Alfonso, F.  et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J. Am. Coll. Cardiol. 47, 2152\u20132160 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jacc.2006.10.049","volume":"49","author":"A Dibra","year":"2007","unstructured":"Dibra, A.  et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J. Am. Coll. Cardiol. 49, 616\u2013623 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR42","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","volume":"119","author":"M Unverdorben","year":"2009","unstructured":"Unverdorben, M.  et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119, 2986\u20132994 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR43","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2009.04.082","volume":"54","author":"F Alfonso","year":"2009","unstructured":"Alfonso, F.  et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. J. Am. Coll. Cardiol. 54, 1036\u20131038 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR44","first-page":"473","volume":"60","author":"RA Byrne","year":"2012","unstructured":"Byrne, R. A., Joner, M., Tada, T. & Kastrati, A. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging. Minerva Cardioangiol. 60, 473\u2013489 (2012).","journal-title":"Minerva Cardioangiol."},{"key":"BFnrcardio2013165_CR45","doi-asserted-by":"publisher","unstructured":"Nakano, M.  et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/eht241\n                    \n                  .","DOI":"10.1093\/eurheartj\/eht241"},{"key":"BFnrcardio2013165_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcin.2010.09.027","volume":"4","author":"A Latib","year":"2011","unstructured":"Latib, A.  et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc. Interv. 4, 155\u2013164 (2011).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jcin.2010.11.008","volume":"4","author":"A Kastrati","year":"2011","unstructured":"Kastrati, A. & Byrne, R. New roads, new ruts: lessons from drug-eluting stent restenosis. JACC Cardiovasc. Interv. 4, 165\u2013167 (2011).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1253\/circj.CJ-12-0610","volume":"77","author":"R Nagoshi","year":"2013","unstructured":"Nagoshi, R.  et al. Qualitative and quantitative assessment of stent restenosis by optical coherence tomography\u2014comparison between drug-eluting and bare-metal stents. Circ. J. 77, 652\u2013660 (2013).","journal-title":"Circ. J."},{"key":"BFnrcardio2013165_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.amjcard.2008.09.107","volume":"103","author":"DH Steinberg","year":"2009","unstructured":"Steinberg, D. H.  et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am. J. Cardiol. 103, 491\u2013495 (2009).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio2013165_CR50","volume-title":"EuroIntervention","author":"RA Byrne","year":"2013","unstructured":"Byrne, R. A.  et al. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials. EuroIntervention \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcin.2010.10.012","volume":"4","author":"S Habara","year":"2011","unstructured":"Habara, S.  et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc. Interv. 4, 149\u2013154 (2011).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR52","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ahj.2013.07.002","volume":"166","author":"S Habara","year":"2013","unstructured":"Habara, S.  et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am. Heart J. 166, 527\u2013533.e2 (2013).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2013165_CR53","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","volume":"59","author":"H Rittger","year":"2012","unstructured":"Rittger, H.  et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J. Am. Coll. Cardiol. 59, 1377\u20131382 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR54","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","volume":"381","author":"RA Byrne","year":"2013","unstructured":"Byrne, R. A.  et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381, 461\u2013467 (2013).","journal-title":"Lancet"},{"key":"BFnrcardio2013165_CR55","doi-asserted-by":"publisher","unstructured":"Kwong, J. S. & Yu, C. M. Drug-eluting balloons for coronary artery disease: an updated meta-analysis of randomized controlled trials. Int. J. Cardiol. \n                    http:\/\/dx.doi.org\/10.1016\/j.ijcard.2013.03.180\n                    \n                  .","DOI":"10.1016\/j.ijcard.2013.03.180"},{"key":"BFnrcardio2013165_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/heartjnl-2012-302945","volume":"99","author":"A Indermuehle","year":"2013","unstructured":"Indermuehle, A.  et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 99, 327\u2013333 (2013).","journal-title":"Heart"},{"key":"BFnrcardio2013165_CR57","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","volume":"30","author":"J Wohrle","year":"2012","unstructured":"Wohrle, J.  et al. SeQuent Please World Wide Registry: clinical results of SeQuent Please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J. Am. Coll. Cardiol. 30, 1733\u20131738 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4244\/EIJV7I6A113","volume":"7","author":"PR Stella","year":"2011","unstructured":"Stella, P. R.  et al. The Valentines trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention 7, 705\u2013710 (2011).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.carrev.2012.06.002","volume":"13","author":"C Hehrlein","year":"2012","unstructured":"Hehrlein, C.  et al. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis first-in-man (PEPPER) trial. Cardiovasc. Revasc. Med. 13, 260\u2013264 (2012).","journal-title":"Cardiovasc. Revasc. Med."},{"key":"BFnrcardio2013165_CR60","doi-asserted-by":"publisher","unstructured":"Almalla, M., Schr\u00f6der, J., Pross, V., Marx, N. & Hoffmann, R. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Catheter. Cardiovasc. Interv. \n                    http:\/\/dx.doi.org\/10.1002\/ccd.25072\n                    \n                  .","DOI":"10.1002\/ccd.25072"},{"key":"BFnrcardio2013165_CR61","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4244\/EIJV8I4A70","volume":"8","author":"P Bondesson","year":"2012","unstructured":"Bondesson, P.  et al. Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention 8, 444\u2013449 (2012).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jcin.2012.12.132","volume":"6","author":"P Agostoni","year":"2013","unstructured":"Agostoni, P.  et al. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve. JACC Cardiovasc. Interv. 6, 569\u2013576 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys, P. W.  et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 331, 489\u2013495 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman, D. L.  et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331, 496\u2013501 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR65","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Sch\u00f6mig","year":"1996","unstructured":"Sch\u00f6mig, A.  et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med. 334, 1084\u20131089 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR66","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/hrt.2011.226563","volume":"97","author":"J Wohrle","year":"2011","unstructured":"Wohrle, J.  et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 97, 1338\u20131342 (2011).","journal-title":"Heart"},{"key":"BFnrcardio2013165_CR67","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","volume":"59","author":"A Belkacemi","year":"2012","unstructured":"Belkacemi, A.  et al. First results of the DEB-AMI (Drug Eluting Balloon in Acute ST-segment elevation Myocardial Infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J. Am. Coll. Cardiol. 59, 2327\u20132337 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR68","doi-asserted-by":"publisher","unstructured":"Clever, Y. P.  et al. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function\u2014comparison with a drug eluting stent and a bare metal stent. Catheter. Cardiovasc. Interv. \n                    http:\/\/dx.doi.org\/10.1002\/ccd.25184\n                    \n                  .","DOI":"10.1002\/ccd.25184"},{"issue":"Suppl. K","key":"BFnrcardio2013165_CR69","doi-asserted-by":"publisher","first-page":"K83","DOI":"10.4244\/EIJV7SKA15","volume":"7","author":"RM Ali","year":"2011","unstructured":"Ali, R. M.  et al. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7 (Suppl. K), K83\u2013K92 (2011).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","volume":"33","author":"PW Serruys","year":"2011","unstructured":"Serruys, P. W., Garcia-Garcia, H. M. & Onuma, Y. From metallic cages to transient bioresorbable scaffolds. Change in paradigm of coronary revascularization in the upcoming decade? Eur. Heart J. 33, 16\u201325 (2011).","journal-title":"Eur. Heart J."},{"issue":"Suppl. K","key":"BFnrcardio2013165_CR71","doi-asserted-by":"publisher","first-page":"K57","DOI":"10.4244\/EIJV7SKA10","volume":"7","author":"U Zeymer","year":"2011","unstructured":"Zeymer, U. & Scheller, B. PCI in small vessels: the case for a drug-coated balloon based intervention. EuroIntervention 7 (Suppl. K), K57\u2013K60 (2011).","journal-title":"EuroIntervention"},{"issue":"Suppl. K","key":"BFnrcardio2013165_CR72","doi-asserted-by":"publisher","first-page":"K47","DOI":"10.4244\/EIJV7SKA8","volume":"7","author":"RA Byrne","year":"2011","unstructured":"Byrne, R. A. & Kastrati, A. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice? EuroIntervention 7 (Suppl. K), K47\u2013K52 (2011).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00392-009-0101-6","volume":"99","author":"M Unverdorben","year":"2010","unstructured":"Unverdorben, M.  et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 99, 165\u2013174 (2010).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio2013165_CR74","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","volume":"96","author":"B Cortese","year":"2010","unstructured":"Cortese, B.  et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial: the PICCOLETO study. Heart 96, 1291\u20131296 (2010).","journal-title":"Heart"},{"key":"BFnrcardio2013165_CR75","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","volume":"60","author":"A Latib","year":"2012","unstructured":"Latib, A.  et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J. Am. Coll. Cardiol. 60, 2473\u20132480 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR76","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jacc.2012.11.067","volume":"61","author":"F Alfonso","year":"2013","unstructured":"Alfonso, F., C\u00e1rdenas, A., Cuevas, C. & P\u00e9rez-Vizcayno, M. J. Paclitaxel-eluting balloons for small-vessel disease. J. Am. Coll. Cardiol. 61, 1831\u20131832 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR77","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/ccd.23499","volume":"80","author":"PR Stella","year":"2012","unstructured":"Stella, P. R.  et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter. Cardiovasc. Interv. 80, 1138\u20131146 (2012).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR78","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jcin.2012.08.005","volume":"5","author":"JP Loh","year":"2012","unstructured":"Loh, J. P. & Waksman, R. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc. Interv. 5, 1001\u20131012 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR79","first-page":"81","volume":"26","author":"L Norgren","year":"2007","unstructured":"Norgren, L.  et al. Inter-society consensus for the management of peripheral arterial disease. Int. Angiol. 26, 81\u2013157 (2007).","journal-title":"Int. Angiol."},{"key":"BFnrcardio2013165_CR80","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger, M.  et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N. Engl. J. Med. 354, 1879\u20131888 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","volume":"116","author":"H Krankenberg","year":"2007","unstructured":"Krankenberg, H.  et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 116, 285\u2013292 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR82","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa0706356","volume":"358","author":"G Tepe","year":"2008","unstructured":"Tepe, G.  et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med. 358, 689\u2013699 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013165_CR83","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","volume":"118","author":"M Werk","year":"2008","unstructured":"Werk, M.  et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 118, 1358\u20131365 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR84","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","volume":"5","author":"M Werk","year":"2012","unstructured":"Werk, M.  et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ. Cardiovasc. Interv. 5, 831\u2013840 (2012).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR85","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","volume":"5","author":"S Cassese","year":"2012","unstructured":"Cassese, S.  et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ. Cardiovasc. Interv. 5, 582\u2013589 (2012).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR86","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","volume":"6","author":"A Micari","year":"2013","unstructured":"Micari, A.  et al. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry. JACC Cardiovasc. Interv. 6, 282\u2013289 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio2013165_CR87","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.jacc.2012.07.033","volume":"60","author":"E Stabile","year":"2012","unstructured":"Stabile, E.  et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J. Am. Coll. Cardiol. 60, 1739\u20131742 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR88","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.4244\/EIJV8I11A203","volume":"8","author":"M Fusaro","year":"2013","unstructured":"Fusaro, M., Cassese, S. & Byrne, R. A. How should I treat a restenosis after superficial femoral artery stenting? EuroIntervention 8, 1342\u20131345 (2013).","journal-title":"EuroIntervention"},{"key":"BFnrcardio2013165_CR89","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jacc.2011.05.034","volume":"58","author":"A Schmidt","year":"2011","unstructured":"Schmidt, A.  et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J. Am. Coll. Cardiol. 58, 1105\u20131109 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013165_CR90","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","volume":"19","author":"F Fanelli","year":"2012","unstructured":"Fanelli, F.  et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J. Endovasc. Ther. 19, 571\u2013580 (2012).","journal-title":"J. Endovasc. Ther."},{"key":"BFnrcardio2013165_CR91","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","volume":"128","author":"F Liistro","year":"2013","unstructured":"Liistro, F.  et al. Drug-Eluting Balloon in peripherAl inTErvention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128, 615\u2013621 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio2013165_CR92","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns, W.  et al. Guidelines on myocardial revascularization. Eur. Heart J. 31, 2501\u20132555 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013165_CR93","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00392-012-0428-2","volume":"101","author":"K Bonaventura","year":"2012","unstructured":"Bonaventura, K.  et al. Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease. Clin. Res. Cardiol. 101, 573\u2013584 (2012).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio2013165_CR94","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR95","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2011)."},{"key":"BFnrcardio2013165_CR96","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio2013165_CR97","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2011)."},{"key":"BFnrcardio2013165_CR98","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio2013165_CR99","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio2013165_CR100","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR101","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR102","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR103","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio2013165_CR104","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR105","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR106","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR107","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio2013165_CR108","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR109","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR110","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR111","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR112","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2010)."},{"key":"BFnrcardio2013165_CR113","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2010)."},{"key":"BFnrcardio2013165_CR114","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR115","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrcardio2013165_CR116","unstructured":"Current Controlled Trials Ltd. ControlledTrials.com \n                    [online]\n                    \n                  , (2013)."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2013.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:51:54Z","timestamp":1684453914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,5]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFnrcardio2013165"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2013.165","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,5]]}}}